Simvastatin prevents and reverses depigmentation in a mouse model of vitiligo
about
Recent advances in understanding vitiligoCellular stress and innate inflammation in organ-specific autoimmunity: lessons learned from vitiligo.Exosomes derived from atorvastatin-modified bone marrow dendritic cells ameliorate experimental autoimmune myasthenia gravis by up-regulated levels of IDO/Treg and partly dependent on FasL/Fas pathway.Vitiligo blood transcriptomics provides new insights into disease mechanisms and identifies potential novel therapeutic targets.Advances in Vitiligo: An Update on Medical and Surgical Treatments.Basic fibroblast growth factor promotes melanocyte migration via activating PI3K/Akt-Rac1-FAK-JNK and ERK signaling pathways.Understanding mechanisms of autoimmunity through translational research in vitiligo.Understanding autoimmunity of vitiligo and alopecia areata.Construction of a Comprehensive Protein-Protein Interaction Map for Vitiligo Disease to Identify Key Regulatory Elements: A Systemic Approach.Interactome analysis of gene expression profile reveals potential novel key transcriptional regulators of skin pathology in vitiligo.Vitiligo Pathogenesis and Emerging Treatments.The role of the Th1 chemokine CXCL10 in vitiligo.Interfering with the IFN-γ/CXCL10 pathway to develop new targeted treatments for vitiligo.PD-L1 reverses depigmentation in Pmel-1 vitiligo mice by increasing the abundance of Tregs in the skin.Unsuccessful Treatment of Alopecia Areata with Simvastatin/Ezetimibe: Experience in 12 Patients.A double-blind, placebo-controlled, phase-II clinical trial to evaluate oral simvastatin as a treatment for vitiligo.Keratinocyte-Derived Chemokines Orchestrate T-Cell Positioning in the Epidermis during Vitiligo and May Serve as Biomarkers of Disease.
P2860
Q28078377-A29A208F-0F08-4C07-8DCF-658FE03CD8F8Q36389114-4696F481-D574-4270-AB88-330459E90A1BQ36454649-506DDE3E-B751-4525-B51B-63995765ED73Q37611016-BE1BD117-C0D2-46CA-876B-A27957C4BB6BQ37634313-77F7493B-4787-48B3-89C4-41B135893B20Q38761387-D678324E-496C-4719-A335-B299BE635792Q38808662-8C90EF4D-CBF1-4438-84F2-93AF24E629E7Q38837287-117E74D8-2D6B-4A41-8FED-F28DB9ABE8F5Q38909947-D4415BD6-D434-418D-99AE-D8A0B6457710Q38943432-23A1BAFD-F632-423E-BD32-7CE22C6F36F0Q39187086-C1F054E5-F7E0-4F93-A627-4982D9C27E4AQ40858470-86486D95-D48A-47E6-9A41-46A5EC6E55B5Q43116514-9BFF784D-37AE-4424-B846-347C1097230EQ48162560-0B8AD1BB-9E8D-4887-8DEB-6FF3B9BD01B2Q50210683-B360B150-C372-4D86-8277-CB487AB7B9B4Q51255116-B93EDECA-FDF7-478A-A148-3530AB4AEAD3Q51448115-0FDDE76E-0925-4DA4-83DD-A3444CDC80C8
P2860
Simvastatin prevents and reverses depigmentation in a mouse model of vitiligo
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Simvastatin prevents and reverses depigmentation in a mouse model of vitiligo
@ast
Simvastatin prevents and reverses depigmentation in a mouse model of vitiligo
@en
type
label
Simvastatin prevents and reverses depigmentation in a mouse model of vitiligo
@ast
Simvastatin prevents and reverses depigmentation in a mouse model of vitiligo
@en
prefLabel
Simvastatin prevents and reverses depigmentation in a mouse model of vitiligo
@ast
Simvastatin prevents and reverses depigmentation in a mouse model of vitiligo
@en
P2093
P2860
P356
P1476
Simvastatin prevents and reverses depigmentation in a mouse model of vitiligo
@en
P2093
Christopher A Hunter
Jillian M Richmond
John E Harris
Kingsley I Essien
Louise Randall
Mehdi Rashighi
Priti Agarwal
P2860
P2888
P304
P356
10.1038/JID.2014.529
P407
P577
2014-12-18T00:00:00Z